China Pharma Holdings (CPHI) Other Working Capital Changes (2013 - 2014)
China Pharma Holdings' (CPHI) quarterly Other Working Capital Changes came in at -$51376.0 in Q1 2026, down 6.99% YoY from -$55237.7 in Q1 2025, and down 6.99% on a QoQ basis from -$48019.0 in Q1 2025.
China Pharma Holdings (CPHI) Other Working Capital Changes (2013 - 2014) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Other Working Capital Changes data on file, last reported at -$51376.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 6.99% year-over-year to -$51376.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36821.0 (down 1091.14% YoY) and the FY2025 annual result came in at -$53444.0, down 172.5% from the prior year.
- Other Working Capital Changes retreated to -$51376.0 in Q1 2026, from -$48019.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.0 million in Q4 2014 to a low of -$1.9 million in Q3 2014.
- A 5-year average of -$7805.8 and a median of -$48471.5 in 2022 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 342.39% in 2023, down 688.77% in 2023.
- Tracing CPHI's Other Working Capital Changes over 5 years: stood at $452021.0 in 2022, then tumbled by 118.33% to -$82849.0 in 2023, then surged by 268.16% to $139322.0 in 2024, then sank by 134.47% to -$48019.0 in 2025, then retreated by 6.99% to -$51376.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$51376.0 (Q1 2026), -$48019.0 (Q1 2025), and $139322.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 3.98 Mn |
| Dec 31, 2014 | 3.98 Mn |
| Dec 31, 2014 | 3.98 Mn |
| Sep 30, 2014 | -1.90 Mn |
| Sep 30, 2014 | -1.90 Mn |
| Sep 30, 2014 | -1.90 Mn |
| Jun 30, 2014 | 418,537.00 |
| Jun 30, 2014 | 418,537.00 |
| Jun 30, 2014 | 418,537.00 |
| Mar 31, 2014 | 11,461.00 |
| Mar 31, 2014 | 11,461.00 |
| Mar 31, 2014 | 11,461.00 |
| Sep 30, 2013 | 5,586.00 |
| Sep 30, 2013 | 5,586.00 |
| Sep 30, 2013 | 5,586.00 |
| Jun 30, 2013 | -693,094.00 |
| Jun 30, 2013 | -693,094.00 |
| Jun 30, 2013 | -693,094.00 |
| Mar 31, 2013 | 44,658.00 |
| Mar 31, 2013 | 44,658.00 |